Nalaganje...
Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study
Background: Pain management for cats with degenerative joint disease (DJD) remains a critical unmet need. Recent work has shown promise for a feline-specific anti-nerve growth factor monoclonal antibody (frunevetmab) to deliver safe and effective pain management. Our objectives were to evaluate the...
Shranjeno v:
| izdano v: | Front Vet Sci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8195238/ https://ncbi.nlm.nih.gov/pubmed/34124212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2021.610028 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|